Could Jack Draper Follow the Path of Robin Soderling?

The summer of 2011 should have been Robin Soderling's.

He was ranked No. 4 in the world, had reached consecutive French Open finals, and had beaten Rafael Nadal at Roland Garros in 2009, the only player to do so on clay before 2015. He was 26 years old and playing some of the best tennis of his life. Then, in July, he felt something was wrong. He played on anyway.

Advertisement

He won the Swedish Open in Bastad, which turned out to be the last professional match he would ever play. Shortly after, he was diagnosed with mononucleosis, the viral infection that had been draining him for weeks. He tried to come back for four years. He never did.

In December 2015, he retired.

Could Draper Follow the Path of Soderling?

Jack Draper has not been diagnosed with mononucleosis. His injury is a bone bruise in his dominant left arm, a different condition with different implications. The parallel is not medical. It is a trajectory interrupted at the exact moment it was supposed to accelerate, by a persistent, poorly understood physical problem that does not follow a timetable and does not respond to willpower alone.

Advertisement

And the question it raises, the uncomfortable one that the tennis world has been tiptoeing around since Draper pulled out of the 2026 US Open last week, is how long a career can absorb this kind of damage before the window closes.

What Draper Was Before the Injury

To understand what is at stake, it helps to trace exactly how high Draper had climbed before the arm started talking back.

In 2024, he announced himself as a genuine major contender in the clearest possible terms. He won titles in Stuttgart and Vienna. He reached the US Open semifinals, going through the draw without dropping a set, beating Tomas Machac and Alex de Minaur in successive rounds before losing to eventual champion Jannik Sinner in a match where he was physically sick on court and still pushed the world No. 1 deep into the night.

Advertisement

He was 22 years old, just the fourth British man to reach the Flushing Meadows semifinals in the Open Era. He was already being spoken about in the same breath as Sinner and Alcaraz as the players who would define the next decade of the sport.

The first months of 2025 only accelerated those expectations. He won his first Masters 1000 title at Indian Wells, beating Alcaraz in the semifinals along the way. He reached the final in Madrid. He climbed to a career-high ranking of No. 4 in the world in June 2025, just days after his 23rd birthday. At Roland Garros, he reached the second week for the first time. The arc of his career was pointing in exactly one direction, and it was pointing steeply upward.

Then the arm.

A Year and a Half of the Same Story

What has happened since is not the story of a straightforward injury with a straightforward recovery. It is the story of a problem that keeps coming back.

Advertisement

The bone bruise in his dominant left arm first surfaced during the clay-court season in 2025. He withdrew from the US Open in August of that year after one win, the first time a men's top-five seed had withdrawn mid-tournament at Flushing Meadows in the Open Era. He then shut down his season entirely, sitting out the remainder of 2025, and subsequently missed the Australian Open at the start of this year.

He returned to form briefly in early 2026 before retiring in Barcelona with a knee injury. He came back at Eastbourne in June and reached the semifinals, winning three matches in what looked like a genuine step forward. Then the arm resurfaced again, forcing him to withdraw from Wimbledon. He returned at Montreal in August, where he broke down in tears during a first-round defeat. He lost in the first round in Cincinnati to a player ranked 67th in the world. Then, last week, he withdrew from the US Open. Not a single Grand Slam match played in 2026.

He has tumbled from world No. 4 to beyond the top 140. He has switched his strings and his racket and has been working to modify his serving action to reduce the load on his arm. None of it has worked so far, and there is no guarantee it will.

What Soderling Felt Like From the Inside

Robin Soderling has spoken, in the years since his retirement, about what those months felt like in real time. He has said that, in his head, he had many more years left in tennis and that he was at the peak of his career when he got sick. For a long time before he was even diagnosed, he was stressed, tired, and run down, and through all of it he kept playing.

Advertisement

That last part matters most. He played through it. He kept competing even as his body was already shutting down. By the time he understood what was happening, the damage had accumulated beyond what recovery could undo.

The mononucleosis contributed to additional complications, including a wrist injury requiring surgery, and from 2012 to 2013 his immune system issues remained chronic, with symptoms flaring up intermittently and causing him to miss numerous tournaments. His ranking dropped to No. 119 by mid-2013. He tried for four years to get back. The body never cooperated. When he finally retired in December 2015, at 31, he said he had realised he would not be fit enough to play tennis at the level he demanded of himself.

The cruelty of Soderling's situation was not just the illness itself. It was the timing. He was not a veteran in decline. He was a player with years of prime tennis still ahead of him, beating Federer and Nadal at Grand Slams, winning Masters titles, ranked inside the top five, with the game to go even further. The illness did not catch the tail end of a career. It cut the career short.

The Uncomfortable Similarities

Draper's situation is different in its specifics and not different enough in its shape. He is 24 years old and ranked 143rd in the world. He has played 15 matches in 2026. His injury has now cost him, in total, the better part of fifteen months, interrupted by partial returns that each ended with the problem reasserting itself.

Advertisement

A bone bruise in his dominant arm is particularly troubling because the left arm is the arm he serves with. Every serve in every practice session, every match, every warm-up is running through that arm. And there is no magic trick around it.

The Soderling comparison isn't a prediction of the same outcome; it's a recognition of the same structural threat. Both players reached No. 4 in the world before something derailed their careers and didn't respond to conventional treatment timelines. Both players had established themselves as genuine threats at the majors, not peripheral top-ten fillers but players with the game to win Slams.

Both were in the middle of what should have been the ascending phase of long careers. And both found themselves watching Grand Slams from the outside, saying publicly they were doing everything possible to get back, while weeks turned into months and their rankings kept falling.

The tennis world wants to believe this is a temporary setback. The evidence of the last fifteen months makes that optimism harder to sustain with every fresh withdrawal. He has said the injury is complex. He has tried everything. It keeps coming back.

Advertisement

The Last Word

The differences matter. Mononucleosis is a viral illness that devastated Soderling's immune system for years; a bone bruise, in theory, is a structural injury that can heal with sufficient rest and load management.

Draper is younger than Soderling was at his peak. Medicine has improved. And there is genuine evidence, in the Eastbourne run in June where he won three matches and reached the semifinals, that the level has not gone anywhere. When he is healthy, even briefly, the tennis is still there.

But the pattern has to be acknowledged honestly. This is not the first injury of Draper's career. He missed much of 2023 with a shoulder injury. He has retired mid-match at events. The bone bruise in the arm has now caused four separate significant absences across two seasons. At some point, the question stops being when Draper will get healthy and starts being whether his body will allow him to stay healthy long enough to build on what he showed at his peak.

Advertisement

That is the question Robin Soderling could not answer. He tried for four years, and the answer turned out to be no. Jack Draper is still young enough that the question remains genuinely open. But it is no longer the type of question that gets dismissed with a reassuring reference to his talent and his age. The talent was never in doubt. The talent has not been the problem.

And if there is one thing the story of Robin Soderling teaches, it is that talent, without the physical foundation to express it, is eventually just a reminder of what might have been.

Click here to read article